Sun Pharmaceutical Industries said that it has raised Rs 1,000 crore through issuing non-convertible debentures (NCDs) on private placement basis. It said in a BSE...
The pharma major Sun Pharma has entered into an agreement with Israel’s Weizmann Institute of Science and Spain’s Health Research Institute of Santiago de Compostela...
India’s largest drug maker Sun Pharmaceutical announced that it has got USFDA approval for generic copies of Gleevec, a drug that treats chronic myeloid leukemia...